[Strategies to slow the progression of chronic kidney disease].

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Presse medicale

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 17656065
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Statins for improving renal outcomes: a meta-analysis.

  2006cited by this paper
• [Should we still prescribe a low protein diet in chronic kidney disease?].

  2006cited by this paper
• Efficacy and safety of benazepril for advanced chronic renal insufficiency.

  2006cited by this paper
• Normalization of hemoglobin level in patients with chronic kidney disease and anemia.

  2006cited by this paper
• [Treatment strategies to slow the progression of chronic renal failure in adults].

  2005cited by this paper
• Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis.

  2005cited by this paper
• Diuretic and enhanced sodium restriction results in improved antiproteinuric response to RAS blocking agents.

  2005cited by this paper
• Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.

  2004cited by this paper
• The renoprotective effects of structured care in a clinical trial setting in type 2 diabetic patients with nephropathy.

  2004cited by this paper
• Combination treatment of angiotensin-II receptor blocker and angiotensin-converting-enzyme inhibitor in non-diabetic renal disease (COOPERATE): a randomised controlled trial.

  2003cited by this paper
• Progression of Chronic Kidney Disease: The Role of Blood Pressure Control, Proteinuria, and Angiotensin-Converting Enzyme Inhibition: A Patient-Level Meta-Analysis

  2003cited by this paper
• Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).

  2002cited by this paper
• Low protein diets and outcome of renal patients.

  2001cited by this paper
• Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively.

  2001cited by this paper
• Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes.

  2001cited by this paper
• Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy.

  2001cited by this paper
• The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes.

  2001cited by this paper
• Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study

  2000cited by this paper
• Mechanisms of progression of chronic renal damage.

  1999cited by this paper
• Smoking as a risk factor for end-stage renal failure in men with primary renal disease.

  1998cited by this paper
• Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39

  1998cited by this paper
• Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38

  1998cited by this paper
• Angiotensin converting enzyme inhibitor-induced renal dysfunction in atherosclerotic renovascular disease.

  1998cited by this paper
• Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy.

  1998cited by this paper
• Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group.

  1996cited by this paper
• Prevalence of hypertension in 1,795 subjects with chronic renal disease: the modification of diet in renal disease study baseline cohort. Modification of Diet in Renal Disease Study Group.

  1996cited by this paper
• The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group.

  1994cited by this paper
• Randomised controlled trial of enalapril and β blockers in non- diabetic chronic renal failure

  1994cited by this paper
• Body building, high-protein diet, and progressive renal failure in chronic glomerulonephritis.

  1993cited by this paper
• The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group.

  1993cited by this paper
• Effects of dietary interventions on glomerular pathophysiology.

  1990cited by this paper

• [How to delay progression of chronic renal failure?].

  2009cites this paper